Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
PDE3B [1] PDE3B 💬Apelin signaling pathway
|
Cilostazol Cilostazol 💬Apelin signaling pathway
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬1. Apelin signaling pathway
|
||||||||||||||||||||||||||
| 2 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
TBXA2R [1] TBXA2R 💬Calcium signaling pathway
|
Cilostazol Cilostazol 💬Calcium signaling pathway
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬2. Calcium signaling pathway
|
||||||||||||||||||||||||||
| 3 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
PDE3A [2] PDE3A, PDE3B 💬
|
Cilostazol Cilostazol 💬cAMP signaling pathway
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬3. cAMP signaling pathway
|
||||||||||||||||||||||||||
| 4 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE3A [2] PDE3A, PDE3B 💬
|
Cilostazol Cilostazol 💬cGMP-PKG signaling pathway
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬4. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||
| 5 | Cholinergic synapse 💬 32 genes, 65 drugs (DrugBank) and 87 diseases |
ACHE [1] ACHE 💬Cholinergic synapse
|
Donepezil hydrochloride Donepezil hydrochloride 💬Cholinergic synapse
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬5. Cholinergic synapse
|
||||||||||||||||||||||||||
| 6 | Cholinergic synapse 💬 32 genes, 65 drugs (DrugBank) and 87 diseases |
ACHE [1] ACHE 💬Cholinergic synapse
|
Donepezil Donepezil 💬Cholinergic synapse
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬5. Cholinergic synapse
|
||||||||||||||||||||||||||
| 7 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F2 [1] F2 💬Complement and coagulation cascades
|
Dabigatran Dabigatran 💬Complement and coagulation cascades
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬7. Complement and coagulation cascades
|
||||||||||||||||||||||||||
| 8 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
F2 [1] F2 💬Coronavirus disease
|
Dabigatran Dabigatran 💬Coronavirus disease
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬8. Coronavirus disease
|
||||||||||||||||||||||||||
| 9 | Glucagon signaling pathway 💬 15 genes, 26 drugs (DrugBank) and 85 diseases |
PDE3B [1] PDE3B 💬Glucagon signaling pathway
|
Cilostazol Cilostazol 💬Glucagon signaling pathway
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬9. Glucagon signaling pathway
|
||||||||||||||||||||||||||
| 10 | Glycerophospholipid metabolism 💬 1 gene, 7 drugs (DrugBank) and 13 diseases |
ACHE [1] ACHE 💬Glycerophospholipid metabolism
|
Donepezil hydrochloride Donepezil hydrochloride 💬Glycerophospholipid metabolism
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬10. Glycerophospholipid metabolism
|
||||||||||||||||||||||||||
| 11 | Glycerophospholipid metabolism 💬 1 gene, 7 drugs (DrugBank) and 13 diseases |
ACHE [1] ACHE 💬Glycerophospholipid metabolism
|
Donepezil Donepezil 💬Glycerophospholipid metabolism
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬10. Glycerophospholipid metabolism
|
||||||||||||||||||||||||||
| 12 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
CALCA [1] CALCA 💬Hormone signaling
|
Fremanezumab Fremanezumab 💬Hormone signaling
| Fremanezumab | 124 [2] 124, 226 💬12. Hormone signaling
|
||||||||||||||||||||||||||
| 13 | Insulin signaling pathway 💬 13 genes, 28 drugs (DrugBank) and 74 diseases |
PDE3B [1] PDE3B 💬Insulin signaling pathway
|
Cilostazol Cilostazol 💬Insulin signaling pathway
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬13. Insulin signaling pathway
|
||||||||||||||||||||||||||
| 14 | Morphine addiction 💬 43 genes, 70 drugs (DrugBank) and 80 diseases |
PDE3A [2] PDE3A, PDE3B 💬
|
Cilostazol Cilostazol 💬Morphine addiction
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬14. Morphine addiction
|
||||||||||||||||||||||||||
| 15 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ACHE [1] ACHE 💬Neuroactive ligand signaling
|
Donepezil hydrochloride Donepezil hydrochloride 💬Neuroactive ligand signaling
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬15. Neuroactive ligand signaling
|
||||||||||||||||||||||||||
| 16 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ACHE [1] ACHE 💬Neuroactive ligand signaling
|
Donepezil Donepezil 💬Neuroactive ligand signaling
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬15. Neuroactive ligand signaling
|
||||||||||||||||||||||||||
| 17 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
CALCA [1] CALCA 💬Neuroactive ligand-receptor interaction
|
Fremanezumab Fremanezumab 💬Neuroactive ligand-receptor interaction
| Fremanezumab | 124 [2] 124, 226 💬17. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||
| 18 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
F2 [1] F2 💬Neuroactive ligand-receptor interaction
|
Dabigatran Dabigatran 💬Neuroactive ligand-receptor interaction
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬18. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||
| 19 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
TBXA2R [1] TBXA2R 💬Neuroactive ligand-receptor interaction
|
Cilostazol Cilostazol 💬Neuroactive ligand-receptor interaction
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬19. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||
| 20 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
F2 [1] F2 💬Pathogenic Escherichia coli infection
|
Dabigatran Dabigatran 💬Pathogenic Escherichia coli infection
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬20. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||
| 21 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
F2 [1] F2 💬Pathways in cancer
|
Dabigatran Dabigatran 💬Pathways in cancer
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬21. Pathways in cancer
|
||||||||||||||||||||||||||
| 22 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
F2 [1] F2 💬Phospholipase D signaling pathway
|
Dabigatran Dabigatran 💬Phospholipase D signaling pathway
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬22. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||
| 23 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
F2 [1] F2 💬Platelet activation
|
Dabigatran Dabigatran 💬Platelet activation
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬23. Platelet activation
|
||||||||||||||||||||||||||
| 24 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
TBXA2R [1] TBXA2R 💬Platelet activation
|
Cilostazol Cilostazol 💬Platelet activation
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬24. Platelet activation
|
||||||||||||||||||||||||||
| 25 | Progesterone-mediated oocyte maturation 💬 14 genes, 39 drugs (DrugBank) and 47 diseases |
PDE3B [1] PDE3B 💬Progesterone-mediated oocyte maturation
|
Cilostazol Cilostazol 💬Progesterone-mediated oocyte maturation
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬25. Progesterone-mediated oocyte maturation
|
||||||||||||||||||||||||||
| 26 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE3A [2] PDE3A, PDE3B 💬
|
Cilostazol Cilostazol 💬Purine metabolism
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬26. Purine metabolism
|
||||||||||||||||||||||||||
| 27 | Regulation of actin cytoskeleton 💬 37 genes, 82 drugs (DrugBank) and 79 diseases |
F2 [1] F2 💬Regulation of actin cytoskeleton
|
Dabigatran Dabigatran 💬Regulation of actin cytoskeleton
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬27. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||
| 28 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PDE3B [1] PDE3B 💬Regulation of lipolysis in adipocytes
|
Cilostazol Cilostazol 💬Regulation of lipolysis in adipocytes
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬28. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||
| 29 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
PDE3A [2] PDE3A, PDE3B 💬
|
Cilostazol Cilostazol 💬Renin secretion
| Cilostazol | 006 [7] 6 , 13, 46, 48, 51, 70, 124 💬29. Renin secretion
|
||||||||||||||||||||||||||
| 30 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
CALCA [1] CALCA 💬Vascular smooth muscle contraction
|
Fremanezumab Fremanezumab 💬Vascular smooth muscle contraction
| Fremanezumab | 124 [2] 124, 226 💬30. Vascular smooth muscle contraction
|
Apelin signaling pathway
18 genes, 37 drugs (DrugBank) and 81 diseases
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Cholinergic synapse
32 genes, 65 drugs (DrugBank) and 87 diseases
Complement and coagulation cascades
21 genes, 46 drugs (DrugBank) and 60 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Glucagon signaling pathway
15 genes, 26 drugs (DrugBank) and 85 diseases
Glycerophospholipid metabolism
1 gene, 7 drugs (DrugBank) and 13 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Insulin signaling pathway
13 genes, 28 drugs (DrugBank) and 74 diseases
Morphine addiction
43 genes, 70 drugs (DrugBank) and 80 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
Pathogenic Escherichia coli infection
31 genes, 46 drugs (DrugBank) and 84 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Progesterone-mediated oocyte maturation
14 genes, 39 drugs (DrugBank) and 47 diseases
Purine metabolism
30 genes, 44 drugs (DrugBank) and 82 diseases
Regulation of actin cytoskeleton
37 genes, 82 drugs (DrugBank) and 79 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Vascular smooth muscle contraction
32 genes, 95 drugs (DrugBank) and 74 diseases
